Sheridan Capital Partners Fund III Closes at Its Hard Cap of $575 Million

Investment Bank Sixpoint Partners Successfully Closes Sheridan Capital Partners Fund III

Sixpoint Partners, a global investment bank, announced today the successful closing of Sheridan Capital Partners Fund III, exceeding its target at $575 million. The Fund, focused on making investments in recession-resistant healthcare industries, will continue Sheridan's strategy of making control investments in North American founder-owned businesses. The oversubscription of the Fund demonstrates the market's confidence in Sheridan's team and strategy.

Sheridan Capital Partners, a Chicago-based healthcare private equity firm, specializes in lower middle-market buyouts and growth equity in the US and Canada. The firm partners with companies in healthcare IT and outsourced services, providers and provider services, and consumer health and medical products, providing strategic resources to accelerate growth and achieve strong results.

Sixpoint Partners, headquartered in New York, is a leading global investment bank focused on delivering strategic advisory and fundraising solutions for the middle-market private equity industry. The firm's core areas of focus include primary fund placement, secondaries advisory, and co-investment placement. Known for its direct and results-driven style, Sixpoint Partners creates long-term value for clients in various industries, strategies, and geographies.

The successful closing of Sheridan Capital Partners Fund III at its hard cap of $575 million highlights the strong reputation of Sheridan in the lower middle-market healthcare space. The oversubscription of the Fund demonstrates the high level of conviction the market has for Sheridan's team and strategy.

Jonathan Lewis, Partner at Sheridan, expressed gratitude to their existing investor base and new strategic partnerships that further diversify their high-quality group of investors across North America, Europe, and the Middle East. He emphasized the excitement surrounding the next phase of growth for the firm as they expand both their team and presence in the lower middle-market healthcare sector.

Sean Dempsey, Partner at Sheridan, acknowledged the partnership with Sixpoint Partners, thanking them for their continued commitment and strategic advice. He also extended his gratitude to the limited partners for their critical role in closing Fund III at $575 million. Dempsey emphasized their eagerness to continue generating value for their investors as the firm grows.

Eric Zoller, Founder & Partner at Sixpoint Partners, commended Sheridan's achievement, highlighting their reputation as a leader in the lower middle-market healthcare industry. Zoller expressed satisfaction in working with Sheridan's team and witnessing their success in a competitive fundraising environment.

Matt Thornton, Partner at Sixpoint Partners, also shared his appreciation for the partnership with Sheridan and the global demand they witnessed from both new and existing investors during the fundraise. Thornton reiterated their commitment to value the partnership and support Sheridan in generating value for their investors.

The successful closing of Sheridan Capital Partners Fund III at its hard cap of $575 million reflects the market's confidence in Sheridan's team and their strategy in the lower middle-market healthcare sector. With the support of their investors and strategic partnerships, Sheridan is poised for significant growth and expansion.